FFECT OF LIRAGLUTIDE ON CARDIOVASCULAR RISK FACTORS AND FUNCTION
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 3
Abstract
Cardiovascular disease is the major cause of death in diabetes. This results from a cluster of risk factors, including high glucose, obesity, hypertension and dyslipidaemia. Liraglutide is the first native GLP-1 analogue and represents a breakthrough approach in type 2 diabetes treatment. Previous data from the LEAD™ programme have shown liraglutide to be a potent glucose regulator, but also to induce weight loss, lower blood pressure, and potentially show improvements in lipid levels, amongst other markers of cardiovascular risk. GLP-1 has also been shown to have an effect on the renal system, as well as the vascular system. Other cardio-protective effects of GLP-1 were proved in animal models: improves cardiac function in heart failure, functional recovery following myocardial ischemia, endothelium dysfunction, increases myocardial glucose uptake and reduces infarct size. Cardiovascular safety of liraglutide was assessed using existing clinical data. The incidence ratio for adjudicated broad/serious major adverse cardiovascular events (MACE) associated with liraglutide was 0.73 (95% CI 0.38–1.41) versus all comparator drugs, within cardiovascular safety limits defined by the United States Food & Drug Administration.
Authors and Affiliations
Maria Mota, Emiliana Mocan, Sorina Botescu
Keywords
Related Articles
- EP ID EP113933
- DOI -
- Views 112
- Downloads 0
Blood Pressure Profile And Glycemic Profile T1DM
The main objective of this study is to analyze the blood pressure profile of patients with type 1 diabetes mellitus and the aspect of the glycemic profile in order to identify the correlations between blood pressure and...
SUBCUTIS DYSTROPHY IN INSULIN TREATED CIRRHOTIC PATIENT
Insulin injections can induce local dystrophies. Many reasons can be but, the most common is the same area repeatedly injected. Our subject is a 50-year-old man insulin treated, also being under medical survey because of...
ACUTE PANCREATITIS IN TYPE 2 DIABETES MELLITUS – IMAGING STUDY
The inflammatory diseases of the pancreas represent an important cause of mortality worldwide and in Romania, so that making some clinical and imaging correlations between these disorders and disturbances of the carbohyd...
ONCE AGAIN ABOUT HEALTHY NUTRITION AND ITS ROLE IN PREVENTION OF TYPE 2 DIABETES
MANAGEMENT OF HYPERTENSION IN DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE
Diabetes mellitus and hypertension are the most common causes of end-stage renal disease. Blood pressure goals in patients with diabetic kidney disease are <130/80 mmHg. The first line therapy for hypertension in thes...